The Gut Microbiome–Antimicrobial Resistance Nexus: Emerging Challenges and Innovative Strategies Against Dysbiosis
The Gut Microbiome–Antimicrobial Resistance Nexus: Emerging Challenges and Innovative Strategies Against Dysbiosis
Soma lotfi1
1) Bachelor of Cell Biology-Microbiology, Faculty of Life Sciences, Islamic Azad University, Pishva Branch, Tehran Province, Iran.
IOI Code
:
AAGF-AAGACC
Publication :
9th International Conference on Applied Researches in Science & Engineering (carseconf.com/9th)
Abstract :
Antimicrobial resistance (AMR) has emerged as a critical global health threat, driven in part by the gut microbiome’s role as both a reservoir and conduit for antimicrobial resistance genes (ARGs). The intricate ecological dynamics of the intestinal microbiota—shaped by host factors, environmental exposures, and therapeutic interventions—create conditions conducive to the selection, maintenance, and dissemination of ARGs through horizontal gene transfer (HGT) mechanisms such as conjugation, transformation, and transduction. This review synthesizes current literature to elucidate mechanistic links between gut dysbiosis and the resistome, with specific reference to clinically significant ARGs (e.g., blaCTX-M, blaNDM, blaKPC, mcr). Methods involved a structured literature survey of peer‑reviewed studies from biomedical databases, complemented by One Health and metagenomic surveillance reports. Emphasis was placed on multi‑omic analyses (metagenomics, metatranscriptomics, metabolomics) that characterize baseline microbial ecology, perturbations due to antibiotics, diet, or infection, and shifts in resistome composition. We also examined clinical case reports, population‑scale surveillance datasets, and experimental models to triangulate evidence. To ensure translational relevance, parallel developments in innovative therapeutics and policy frameworks were reviewed. Findings reveal that gut microbiome dysbiosis—whether induced by antibiotic exposure, dietary transitions, hospitalization, or co‑infection—accelerates ARG enrichment and facilitates cross‑species gene dissemination. Dysbiosis disrupts colonization resistance, enabling opportunistic pathogens to expand and mobilize resistance determinants across commensal and pathogenic taxa. Surveillance approaches integrating shotgun metagenomics with targeted qPCR enhance sensitivity for ARG detection, while bioinformatic harmonization remains a key gap. Innovative intervention strategies, including fecal microbiota transplantation (FMT), bacteriophage therapy, targeted prebiotics/probiotics, and CRISPR‑Cas antimicrobials, show promise in restoring microbiome homeostasis and suppressing ARG reservoirs but face translational and regulatory hurdles. In conclusion, the gut microbiome–AMR nexus represents a dynamic and evolving interface with profound clinical and public health implications. Addressing the threat requires coordinated action spanning clinical stewardship, ecological prevention, technological innovation, and policy harmonization under a One Health framework.
Keywords : gut microbiome antimicrobial resistance resistome horizontal gene transfer one health